• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice.

OBJECTIVE: An increase in the rate of hepatic glucose production is the major determinant of fasting hyperglycemia in type 2 diabetes. A better understanding of the signaling pathways and molecules that regulate hepatic glucose metabolism is therefore of great clinical importance. Recent studies suggest that an increase in vagal outflow to the liver leads to decreased hepatic glucose production and reduced blood glucose levels. Since acetylcholine (ACh) is the major neurotransmitter of the vagus nerve and exerts its parasympathetic actions via activation of muscarinic ACh receptors (mAChRs), we examined the potential metabolic relevance of hepatocyte mAChRs. RESEARCH DESIGN AND METHODS: We initially demonstrated that the M(3) mAChR is the only mAChR subtype expressed by mouse liver/hepatocytes. To assess the physiological role of this receptor subtype in regulating hepatic glucose fluxes and glucose homeostasis in vivo, we used gene targeting and transgenic techniques to generate mutant mice lacking or overexpressing M(3) receptors in hepatocytes only. RESULTS: Strikingly, detailed in vivo phenotyping studies failed to reveal any significant metabolic differences between the M(3) receptor mutant mice and their control littermates, independent of whether the mice were fed regular or a high-fat diet. Moreover, the expression levels of genes for various key transcription factors, signaling molecules, and enzymes regulating hepatic glucose fluxes were not significantly altered in the M(3) receptor mutant mice. CONCLUSIONS: This rather surprising finding suggests that the pronounced metabolic effects mediated by activation of hepatic vagal nerves are mediated by noncholinergic signaling pathways.

Pubmed ID: 19752163

Authors

  • Li JH
  • Gautam D
  • Han SJ
  • Guettier JM
  • Cui Y
  • Lu H
  • Deng C
  • O'Hare J
  • Jou W
  • Gavrilova O
  • Buettner C
  • Wess J

Journal

Diabetes

Publication Data

December 26, 2009

Associated Grants

  • Agency: NIDDK NIH HHS, Id: DK074873
  • Agency: NIDDK NIH HHS, Id: DK082724
  • Agency: NIDDK NIH HHS, Id: K08 DK074873
  • Agency: NIDDK NIH HHS, Id: R01 DK083658
  • Agency: NIDDK NIH HHS, Id: R03 DK082724
  • Agency: Intramural NIH HHS, Id:

Mesh Terms

  • Animals
  • Blood Glucose
  • Blotting, Western
  • Glucose
  • Hepatocytes
  • Kupffer Cells
  • Liver
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Phenotype
  • Receptor, Muscarinic M3
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Up-Regulation